Amphastar Pharma (AMPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 36,768 | 6,420 | 98,094 | 73,665 | 56,315 |
| Depreciation Amortization | 30,295 | 15,109 | 60,050 | 44,843 | 29,829 |
| Income taxes - deferred | N/A | N/A | 28,660 | N/A | N/A |
| Accounts receivable | -1,568 | -4,547 | -6,367 | -9,599 | 4,192 |
| Other Working Capital | 12,726 | 15,305 | -65,971 | -23,242 | -35,239 |
| Other Operating Activity | 20,943 | 15,553 | 41,649 | 37,585 | 15,572 |
| Operating Cash Flow | $99,164 | $47,840 | $156,115 | $123,252 | $70,669 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 48,029 | -7,293 | -28,839 | 23,024 | 35,703 |
| PPE Investments | -18,098 | -9,507 | -34,882 | -26,610 | -21,262 |
| Purchase Sale Intangibles | N/A | N/A | -2,250 | -2,250 | -2,250 |
| Other Investing Activity | -1,794 | 67 | -6,611 | -6,177 | -4,585 |
| Investing Cash Flow | $28,137 | $-16,733 | $-70,332 | $-9,763 | $9,856 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 0 | 6,216 | 5,943 | 5,771 |
| Debt Repayment | -554 | -29 | -223 | -119 | -75 |
| Common Stock Issued | 1,517 | -686 | 2,855 | 873 | 494 |
| Common Stock Repurchased | -74,705 | -29,492 | -75,586 | -55,070 | -50,220 |
| Other Financing Activity | 0 | 0 | -687 | -679 | -675 |
| Financing Cash Flow | $-73,742 | $-30,207 | $-67,425 | $-49,052 | $-44,705 |
| Exchange Rate Effect | -122 | -138 | 210 | 219 | 260 |
| Beginning Cash Position | 170,412 | 170,412 | 151,844 | 151,844 | 151,844 |
| End Cash Position | 223,849 | 171,174 | 170,412 | 216,500 | 187,924 |
| Net Cash Flow | $53,437 | $762 | $18,568 | $64,656 | $36,080 |
| Free Cash Flow | |||||
| Operating Cash Flow | 99,164 | 47,840 | 156,115 | 123,252 | 70,669 |
| Capital Expenditure | -18,098 | -9,507 | -34,882 | -26,610 | -21,262 |
| Free Cash Flow | 81,066 | 38,333 | 121,233 | 96,642 | 49,407 |